FilingReader Intelligence
Pharmedic boosts dividend payout to 62.68% of charter capital
August 6, 2025 at 06:02 PM UTC•By FilingReader AI
Pharmedic Pharmaceutical Medicinal Joint Stock Company increased its 2024 dividend payment ratio from 24% to 62.68% of charter capital, with payments scheduled for February and April 2025.
The decision reflects a shift in profit distribution strategy, reallocating funds from development investment to dividends for shareholders.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HNX:PMC•Hanoi Stock Exchange
News Alerts
Get instant email alerts when Pharmedic Pharmaceutical Medicinal JSC publishes news
Free account required • Unsubscribe anytime